Hyperphosphatemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with chronic kidney disease and disease–mineral and bone disorder in hemodialysis; age range greater than or equal to 18 years; literate or had literate carer; serum phosphorus levels less than or equal to 7,8mg/dL after thirty days of phosphate binder cessation; sign the written informed consent form
Exclusion criteria
Exclusion criteria: Patients in use of anti-inflammatory hormones; patients with neoplasias or active infectious diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in serum levels of phosphorus based on the observation of a negative variation of 5% in the measurements before and after (30 and 60 days) intervention with the Phosphorus Counting Table;Maintenance in serum levels of phosphorus by observing the measurements before and after (30 and 60 days) intervention with the Phosphorus Counting Table | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in 5% of phosphorus intake by means of analysis of phosphorus intake during before and after intervention through 3-d food record;Maintenance of nutritional status by observing the means of body mass index greater than or equal to 18 Kg/m2 and serum levels of total protein between 6 and 8 g/dL, albumin greater than 3,8 g/dL, total lymphocyte count greater than 1200 mm3, creatinine greater than 9 mg/dL, total cholesterol between 100 and 200 mg/dL and transferrin between 250 and 450 mg/dL during the interval before and after intervention | — |
Countries
Brazil
Contacts
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo